Fig. 4From: The optimal neoadjuvant chemotherapy regimen for locally advanced gastric and gastroesophageal junction adenocarcinoma: a systematic review and Bayesian network meta-analysisThe pCR rate of each regimen. A The pCR rate was 11.21% for TPF regimen, 7.21% for ECF regimen, 5.01% for PF regimen and 5.13% for TP regimen. B Forest plots of comparisons for pathological complete response rateBack to article page